[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345940-105":59,"doc-detail-345940-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","choline-metabolism-drives-metastasis-in-brca1-deficient-ovarian-cancers-by-activating-fam3c","Choline metabolism drives metastasis in BRCA1-deficient ovarian cancers by activating FAM3C","","BRCA1 mutations are linked to hereditary ovarian cancer and impaired DNA repair, yet their roles in cancer progression beyond genomic integrity are unclear. Using metabolomics, the study shows BRCA1 deficiency markedly elevates choline metabolism by upregulating CTL4 via EZH2-mediated promoter repression and increased CTL4 expression in tumor tissues. CTL4 activity boosts invasion and metastasis, while CTL4 inhibition reverses the enhanced metastatic potential. The choline metabolite phosphocholine stabilizes FAM3C, promoting EMT, and the CTL4 inhibitor DT-13 suppresses choline metabolism and metastasis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/choline-metabolism-drives-metastasis-in-brca1-deficient-ovarian-cancers-by-activating-fam3c/345940/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/choline-metabolism-drives-metastasis-in-brca1-deficient-ovarian-cancers-by-activating-fam3c/345940.png","ImageObject",300,407,{"name":92,"@type":93},"Seraphina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does BRCA1 deficiency affect choline metabolism?","Question",{"text":112,"@type":113},"BRCA1 deficiency strikingly increases choline metabolism. It promotes choline uptake by upregulating the choline transporter-like protein 4 (CTL4).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is the role of CTL4 in BRCA1-deficient ovarian cancer metastasis?",{"text":117,"@type":113},"CTL4 is overexpressed in ovarian cancer tissues with BRCA1 mutations and promotes invasion and metastasis. Inhibiting CTL4 reverses the high metastatic potential of BRCA1-deficient cells.",{"name":119,"@type":110,"acceptedAnswer":120},"How does phosphocholine relate to FAM3C and EMT?",{"text":121,"@type":113},"Phosphocholine, elevated due to CTL4 overexpression, interacts with and stabilizes the EMT inducer FAM3C in BRCA1-deficient ovarian cancer cells, supporting EMT.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345940,1790564651,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962075114101,"https://ap-avatar.wpscdn.com/avatar/e000253a75eb197efd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780044092746381165","Article [https://doi.org/10.1038/s41467-026-74652-2](https://doi.org/10.1038/s41467-026-74652-2)  \nCholine metabolism drives metastasis in BRCA1-deﬁcient ovarian cancers by activating FAM3C  \nReceived: 7 February 2025  \n\n| Accepted: 9 June 2026 |\n| --- |\n| |\n| Check for updates |\n\nCong Wang1, Xuexia Xie2, Jiahuang Li1, Jiawei Zhu1, Binghe Sun1, Yue Wu3, Wanying Zhang1, Dake Li3 & Guo Chen 1   \nBRCA1 mutations are a hallmark of hereditary ovarian cancer, strongly linked to deﬁciencies in homologous recombination (HR) DNA repair and impaired DNA replication fork protection. However, its roles in cancer progression beyond maintaining genomic integrity remain poorly understood. Here, through metabolomics approaches, we ﬁnd that BRCA1-deﬁciency strikingly increases choline metabolism. Loss of BRCA1 promotes choline uptake through upregulating choline transporter-like protein 4 (CTL4). BRCA1 directly binds and recruits EZH2-mediated H3K27Me3 deposition to the CTL4 promoter. CTL4 is therefore overexpressed in ovarian cancer tissues with BRCA1 mutations. Furthermore, BRCA1-deﬁciency signiﬁcantly promotes ovarian cancer invasion, while inhibition of CTL4 reverses the high metastatic potential of BRCA1-deﬁcient ovarian cancer cells, suggesting the functionality and speciﬁcity of CTL4 as a therapeutic target. Additionally, we discover that phosphocholine, the choline metabolite increased by CTL4 overexpression, interacts with and stabilizes the epithelial-to-mesenchymal transition inducer FAM3C in BRCA1-deﬁcient ovarian cancer cells. Importantly, we identify a potent CTL4 inhibitor, DT-13, which signiﬁcantly reduces choline metabolism and effectively suppresses metastasis in BRCA1-deﬁcient ovarian cancers. Therefore, our study uncovers a mechanism underlying metastasis in BRCA1-deﬁcient cancers and identiﬁes CTL4 as a therapeutic target for metastatic ovarian cancer patients with BRCA1 mutations.  \nMetabolic reprogramming represents a hallmark of cancer cells and plays critical roles in cancer prognosis1. Among the various metabolic alterations observed in cancer cells, alteration of choline metabolism, characterized by an elevation of choline-containing metabolites such as phosphocholine (Pho-Cho), phosphatidylcholine (PtdCho), and sphingomyelin (SM), has emerged as a crucial feature with profound implications for cancer development and progression2–4. As an essential nutrient, choline is physiologically involved in various biological processes, such as maintaining the  \nstructural integrity of the cell membrane, providing neurotransmitter acetylcholine, and methyl donors5. Key enzymes in choline metabolism, such as choline kinase (CHK), phosphocholine cytidylyltransferase (CCT), and PtdCho-speciﬁc phospholipase D (PC-PLD), are frequently overexpressed or hyperactivated in cancer cells6–8. These enzymes not only contribute to the altered metabolic landscape of cancer but also hold potential as prognostic biomarkers and therapeutic targets. Although the activation of choline metabolism is strongly linked to oncogenic transformation and  \n1School of Biopharmacy, China Pharmaceutical University, Nanjing, China. 2Department of Anesthesiology, The First Afﬁliated Hospital, Jinan University, Guangzhou, China. 3Department of Gynecology, Nanjing Maternity and Child Health Care Hospital, Women’s Hospital of Nanjing Medical University,  \nNanjing, China. e-mail: [gchen84@cpu.edu.cn](gchen84@cpu.edu.cn)  \nprogression, the mechanisms through which it drives cancer progression remain largely unknown.  \nMetabolic rewiring in cancer cells is driven by oncogenes and tumor suppressors to support their proliferation and metastasis potential9–12. BRCA1 is a well-documented cancer predisposition gene, which is frequently mutated in a variety of cancers, particularly in breast and ovarian cancers13. Pathogenic variants in BRCA1 are strongly linked to elevated risks of these cancers. The BRCA1 gene comprises 22 exons that encode a protein consisting of 1863 a","cbCail2lLzxv5CIZ","https://ap.wps.com/l/cbCail2lLzxv5CIZ","pdf",3942551,17,"English","# Abstract\n## Metabolomics findings: BRCA1 deficiency increases choline metabolism\n## CTL4 regulation and therapeutic inhibition (DT-13)\n## Phosphocholine–FAM3C interaction and EMT promotion\n# Background\n## Choline metabolism in cancer progression","[{\"question\":\"How does BRCA1 deficiency affect choline metabolism?\",\"answer\":\"BRCA1 deficiency strikingly increases choline metabolism. It promotes choline uptake by upregulating the choline transporter-like protein 4 (CTL4).\"},{\"question\":\"What is the role of CTL4 in BRCA1-deficient ovarian cancer metastasis?\",\"answer\":\"CTL4 is overexpressed in ovarian cancer tissues with BRCA1 mutations and promotes invasion and metastasis. Inhibiting CTL4 reverses the high metastatic potential of BRCA1-deficient cells.\"},{\"question\":\"How does phosphocholine relate to FAM3C and EMT?\",\"answer\":\"Phosphocholine, elevated due to CTL4 overexpression, interacts with and stabilizes the EMT inducer FAM3C in BRCA1-deficient ovarian cancer cells, supporting EMT.\"}]","Choline metabolism drives metastasis in BRCA1-deficient ovarian cancers by activating FAM3C | PDF",1790059438,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b183f5a1a6b1c50f9cd9ab6863a60864.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d55cd0d218927a44b59b1f0b3eb8a13e.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/01567fbd433dc7aff9404d4d41c3945b.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/33c7d91e70eb18b12d9a8939a8c52aba.webp",980,1301]